Adherence to treatment is a key issue in the management of cardiometabolic diseases. Watch the replay of the Cardiometabolic & Venous diseases Forum 2024 sessions discussing solutions to improve adherence.
Watch the replay of the symposium held at EASD 2023, providing new insights regarding the importance of glycemic control in the treatment of T2D, with speakers K. Khunti (UK), J. Chan (Hong Kong) and M. Hassanein (UAE).
Get updated on the holistic management of multimorbid patients in cardiometabolic diseases in this replay of the Cardiometabolic & Venous diseases Forum.
Get updated on the management of dyslipidemia in this replay of the Cardiometabolic & Venous diseases Forum, including discussions on ESC guidelines, latest evidence, and future perspectives in dyslipidemia management.
Discover Servier's symposium on Type 2 Diabetes at the IDF Congress 22, presenting for the first time new real-world evidence of the ADD2DIA Study and a new subanalysis of real-world study using JADE Register.
Learn more about the retrospective study comparing the effectiveness of gliclazide MR 60 mg versus sitagliptin as second-line treatment after metformin monotherapy in patients with uncontrolled T2D.
